Antiviral activity of fattiviracin FV-8 against human immunodeficiency virus type 1 (HIV-1)

Bioscience, Biotechnology and Biochemistry

Volumn 65, Issue 3, 2001, Pages 683-685

  Habib, El Sayed E ^a   Yokomizo, Kazumi ^a   Nagao, Kazuhiko ^a   Harada, Shinji ^a   Uyeda, Masaru ^a  

^a KUMAMOTO UNIVERSITY   (Japan)

Author keywords

Antiviral agent; Fattiviracin; Human immunodeficiency virus type 1; Streptomyces microflavus

Indexed keywords

HERPES; HUMAN HERPESVIRUS 1; HUMAN HERPESVIRUS 3; HUMAN IMMUNODEFICIENCY VIRUS; HUMAN IMMUNODEFICIENCY VIRUS 1; STREPTOMYCES; STREPTOMYCES MICROFLAVUS;

ANTI HUMAN IMMUNODEFICIENCY VIRUS AGENT; ANTIVIRUS AGENT; FATTIVIRACIN FV 8; FATTIVIRACIN FV-8; GLUCOSE; GLYCOLIPID; UNSATURATED FATTY ACID;

ANIMAL; ARTICLE; CELL LINE; CERCOPITHECUS; DOG; DOSE RESPONSE; DRUG EFFECT; HERPES SIMPLEX VIRUS 1; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS 1; INFLUENZA VIRUS A; INFLUENZA VIRUS B; STREPTOMYCES; VARICELLA ZOSTER VIRUS; VERO CELL;

ANIMALS; ANTI-HIV AGENTS; ANTIVIRAL AGENTS; CELL LINE; CERCOPITHECUS AETHIOPS; DOGS; DOSE-RESPONSE RELATIONSHIP, DRUG; FATTY ACIDS, UNSATURATED; GLUCOSE; GLYCOLIPIDS; HERPESVIRUS 1, HUMAN; HERPESVIRUS 3, HUMAN; HIV-1; HUMANS; INFLUENZA A VIRUS; INFLUENZA B VIRUS; STREPTOMYCES; VERO CELLS;

EID: 0035290351     PISSN: 09168451     EISSN: None     Source Type: Journal    
DOI: 10.1271/bbb.65.683     Document Type: Article

References (11)

1. Uyeda, M., Aoki, M., Nakajima, K., Yokomizo, K., Kido, Y., and Kino, Y., A new antiherpetic agent, AH-135Y, produced by Streptomyces albovinaceus strain No. AH-135. J. Antibiotics, 45, 1370-1372 (1992).
2. Uyeda, M., Kondo, K., Ito, A., Yokomizo, K., and Kido, Y., A new antiherpetic agent produced by Streptomyces sp. strain No. 758. J. Antibiotics, 48, 1234-1239 (1995).
3. Uyeda, M., Yokomizo, K., Ito, A., Nakayama, K., Watanabe, H., and Kido, Y., A new antiherpetic agent, AH-1763 IIa, produced by Streptomyces cyaneus strain No. 1763. J. Antibiotics, 50, 483-487 (1997).
4. Uyeda, M., Yokomizo, K., Miyamoto, Y., and Habib, E., Fattiviracin A1, a novel antiherpetic agent produced by Streptomyces microflavus strain No. 2445. I. Taxonomy, fermentation, isolation, physicochemical properties and structure elucidation. J. Antibiotics, 51, 823-828 (1998).
5. Yokomizo, K., Miyamoto, Y., Nagao, K., Kumagae, E., Habib, E., Suzuki, K., Harada, S., and Uyeda, M., Fattiviracin A1, a novel antiviral agent produced by Streptomyces microflavus strain No. 2445. II. Biological properties. J. Antibiotics, 51, 1035-1039 (1998).
6. Habib, E., Yokomizo, K., Murata, K., and Uyeda, M., Structures of Fattiviracin Family, Antiviral Antibiotics. J. Antibiotics, 53, 1420-1423 (2000).
7. Schinazi, R. F., Peters, J., Williams, C. C., Chance, D., and Nahmias, A. J., Effect of combinations of acyclovir with vidarabine or its 5′-monophosphate on herpes simplex viruses in cell culture and in mice. Antimicrob. Agent. Chemother, 22, 499-507 (1982).
8. Kimpton, J. and Emerman, M., Detection of replication-competent and pseudotyped human immunodeficiency virus with a sensitive cell line on the basis of activation of an integrated β-galactosidase gene. J. Virology, 66, 2232-2239 (1992).
9. Dubreuil, M., Sportza, L., D'Addario, M., Lacoste, J., Rooke, R., Wainberg, M. A., and Hiscott, J., Inhibition of HIV-1 transmission by interferon and 3′-azido-3′-deoxythymidine during de novo infection of promonocytic cells. Virology, 179, 388-394 (1990).
10. Furman, P. A., Fyfe, J. A., St Clair, M. H., Weinhold, K., Rideout, J. L., Freeman, G. A., Lehrman, S. N., Bolognesi, D. P., Broder, S., and Mitsuya, H., Phosphorylation of 3′-azido-3′-deoxythymidine and selective interaction of the 5′-triphosphate with human immunodeficiency virus reverse transcriptase. Proc. Natl. Acad. Sci. USA, 83, 8333-8337 (1986).
11. Deeks, S. G., Smith, M., Holodniy, M., and Kahn, J. O., HIV-1 protease inhibitors. A review of clinicans. JAMA, 277, 145-153 (1997).